TNYA insider buying and SEC filings, explained
Tenaya Therapeutics, Inc. · CIK 1858848
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$6.0M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 17, 2026 | Sale | Faraz Ali (CEO and Director) sold 22,232 shares at about $0.7100 ($16K). Holdings down 5% to 417,782 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 17, 2026 |
| Aug 17, 2026 | Sale | Whittemore Tingley (Chief Medical Officer) sold 7,424 shares at about $0.7100 ($5K). Holdings down 3% to 214,073 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 17, 2026 |
| May 18, 2026 | Sale | Faraz Ali (CEO and Director) sold 3,390 shares at $0.7900 ($3K). Holdings down 1% to 440,014 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 18, 2026 | Sale | Whittemore Tingley (Chief Medical Officer) sold 3,121 shares at $0.7900 ($2K). Holdings down 1% to 215,497 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| May 18, 2026 | Sale | Tomohiro Higa (SVP, Finance) sold 1,485 shares at $0.7900 ($1K). Holdings down 1% to 118,267 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 19, 2026 |
| Feb 24–25, 2026 | Sale | Peter Svennilson (10% owner) sold 4,170,266 shares indirectly between Feb 24 and Feb 25 at about $0.5695 ($2.4M). Indirect holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners. | SEC filing Filed Feb 26, 2026 |
| Feb 20–23, 2026 | Sale | Peter Svennilson (10% owner) sold 829,734 shares indirectly between Feb 20 and Feb 23 at about $0.6063 ($503K). Indirect holdings down 27% to 2,211,757 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners. | SEC filing Filed Feb 24, 2026 |
| Feb 17, 2026 | Sale | Tomohiro Higa (SVP, Finance) sold 3,469 shares at about $0.6400 ($2K). Holdings down 3% to 119,752 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Feb 17, 2026 | Sale | Faraz Ali (CEO and Director) sold 14,862 shares at about $0.6400 ($10K). Holdings down 3% to 443,404 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Feb 17, 2026 | Sale | Whittemore Tingley (Chief Medical Officer) sold 5,160 shares at about $0.6400 ($3K). Holdings down 2% to 218,618 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 17, 2026 |
| Feb 10–11, 2026 | Sale | Peter Svennilson (10% owner) sold 4,400,290 shares indirectly between Feb 10 and Feb 11 at about $0.6909 ($3.0M). Indirect holdings down 62% to 2,651,817 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 7 other reporting owners. | SEC filing Filed Feb 12, 2026 |
| Nov 17, 2025 | Sale | Tomohiro Higa (SVP, Finance) sold 1,367 shares at $1.33 ($2K). Holdings down 1% to 93,971 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 17, 2025 |
| Nov 17, 2025 | Sale | Whittemore Tingley (Chief Medical Officer) sold 2,877 shares at $1.33 ($4K). Holdings down 2% to 169,926 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 17, 2025 |
| Nov 17, 2025 | Sale | Faraz Ali (CEO and Director) sold 3,126 shares at $1.33 ($4K). Holdings down 1% to 299,666 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 17, 2025 |
13 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TNYA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.